This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Longenecker, G. L. Articles by King, T. Search for Related Content PubMed PubMed Citation Articles by Longenecker, G. L. Articles by King, T.

Human Rhabdosarcoma Cell-induced Aggregation of Blood Platelets¹

Departments of Biomedical Sciences and Pharmacology, University of South Alabama, Mobile, Alabama 36688

The ability of tumor cells shed into the circulation to cause adhesion and aggregation of blood platelets may be involved in successful metastasis of primary tumors. Rhabdosarcoma is a rare, early metastasizing tumor previously uncharacterized for ability to alter platelet function. It was found that human rhabdosarcoma cells (American Type Culture Collection) dose dependently induce biphasic aggregation of human blood platelets in heparinized platelet-rich plasma; aggregation responses could also be elicited in citrated plasma. Aggregation caused by rhabdosarcoma can be inhibited by apyrase treatment of either rhabdosarcoma or platelets, and by pretreatment of platelets with prostacyclin, cilostamide, inhibitors of thromboxane A₂ production, or TMB-8; only apyrase and prostacyclin inhibited both phases of aggregation. Tumor cell supernatant contained only enough ADP to cause a negligible, reversible aggregation response. Hirudin, verapamil, and triazolam do not inhibit rhabdosarcoma-induced aggregation. Aggregation of platelets by rhabdosarcoma cells thus appears to involve ADP, from tumor cells and/or platelets, and platelet calcium mobilization and thromboxane A₂ synthesis and release.

¹ This work was supported by Grant 0092 to G. L. by the Smokeless Tobacco Research Council.

Received 6/25/87. Revised 6/20/88. Accepted 9/28/88.

This article has been cited by other articles:

				B. Felding-Habermann, R. Habermann, E. Saldívar, and Z. M. Ruggeri Role of beta3 Integrins in Melanoma Cell Adhesion to Activated Platelets under Flow J. Biol. Chem., March 8, 1996; 271(10): 5892 - 5900. [Abstract] [Full Text] [PDF]